indazolebased synthetic cannabinoid potent agonist receptor binding affinity ki nm originally developed pfizer example patent wo tightly binding compound patent terms ki potent compound producing mediated pharmacological effect least compounds patent lower swedens public health agency suggested classifying hazardous substance november following use ingredient greymarket synthetic cannabis cannabinoid related article stub help wikipedia expanding